Skip to Content

How is Vantrela ER formulated to be abuse deterrent?

Answers (1)

Official Answer by Drugs.com 8 Feb 2017

Vantrela ER (hydrocodone bitartrate) extended-release tablets are formulated with Teva Pharmaceutical's abuse-deterrent technology that results in properties that are expected to reduce, but not totally prevent, oral, intranasal and intravenous abuse of the drug when the tablets are manipulated. Teva's proprietary abuse-deterrent technology is based on a multi-layer gel-forming polymer coating that regulates drug release.

Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What is the difference between Fiasp and NovoLog?

Posted 7 Nov 2017 1 answerFAQ by Drugs.com

How is Zilretta administered?

Posted 8 Nov 2017 1 answerFAQ by Drugs.com

What is the cost of Yescarta?

Posted 8 Nov 2017 1 answerFAQ by Drugs.com

How is Yescarta administered?

Posted 8 Nov 2017 1 answerFAQ by Drugs.com

What is the difference between Zostavax and Shingrix?

Posted 8 Nov 2017 1 answerFAQ by Drugs.com